Press Releases

Jun 22, 2026

Nina Shah

Press Releases

Verrica Pharmaceuticals Announces First U.S. Patient Dosed in the Second Pivotal Clinical Trial (COVE-3) of its Phase 3 Program Evaluating YCANTH® (VP-102) for the Treatment of Common Warts

Verrica Pharmaceuticals announced dosing of the first U.S. patient in the COVE-3 Phase 3 clinical trial evaluating YCANTH® (VP-102) for common warts. With a global Phase 3 program ongoing, including its Japanese partner Torii Pharmaceutical, the company targets a significant market with no current FDA-approved treatments. Positive Phase 2 results a…

VRCA

Jun 22, 2026

Avery Klein

Press Releases

Outdoor Holding Company Reports Fourth Quarter and Fiscal Year 2026 Financial Results

Outdoor Holding Company, operator of GunBroker.com, reported a 10.1% revenue increase and significant reduction in operating losses for Q4 and fiscal year 2026, driven by cost reductions, settlement of legacy legal matters, and platform investments including AI enhancements. Adjusted EBITDA more than doubled year-over-year, with improved gross marg…

POWW

Jun 22, 2026

Ajmal Hussain

Press Releases

Westport Announces US$10 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

Westport Fuel Systems Inc. announced a definitive agreement for a $10 million registered direct offering of common shares and a concurrent private placement of warrants priced at-the-market under Nasdaq rules. The company expects to use the net proceeds for working capital and general corporate purposes. If private placement warrants are exercised,…

WPRT

Jun 22, 2026

Caleb Monroe

Press Releases

LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection

LifeMD, a Nasdaq-listed virtual care provider, announced an exclusive telehealth co-marketing partnership with Antares Pharma to launch a direct-to-patient self-pay program for XYOSTED®, the FDA-approved once-weekly testosterone enanthate auto-injector. Launching in July 2026 across 37 states, the program offers virtual evaluation, diagnosis, and h…

LFMD

Jun 22, 2026

Sofia Navarro

Press Releases

Kandi Technologies Accelerates Global Expansion

Kandi Technologies Group, Inc. reports accelerated international expansion of its off-road vehicle business. The company's products are now available in 35 countries and regions, with focused growth in Africa, Southeast Asia, Latin America, and the Middle East through a dual strategy of order expansion and brand localization. Key new dealer partner…

KNDI

Jun 22, 2026

Ajmal Hussain

Press Releases

Veea Strengthens Executive Leadership Team to Accelerate its Commercial Growth and Market Expansion

Veea Inc., a NASDAQ-listed leader in AI-powered edge infrastructure, has promoted Greg Deisher to COO, Mark Tubinis to Executive VP, and appointed Thomas Latiolais as CMO. These leadership changes aim to accelerate revenue growth, strengthen operational execution, and drive global market expansion across enterprise, industrial, and AI-enabled secto…

VEEA

Jun 22, 2026

Marcus Reed

Press Releases

Tyson® Debuts New Garlic & Herb, BBQ, and Harissa Chicken Cups

Tyson Foods has launched three new flavors—Garlic & Herb, BBQ, and Harissa—for its Tyson Chicken Cups, following strong consumer reception and recognition as Product of the Year in the Protein Snack category. The new offerings cater to diverse consumer taste preferences, especially among Millennials and Gen Z, and reinforce Tyson's position in conv…

TSN

Jun 22, 2026

Hana Yamamoto

Press Releases

Refinity Secures Exclusive License to PNNL Catalyst Technology to Convert Olefins into Circular Hydrocarbon Liquids for SAF Production

Refinity, a subsidiary of Innventure, Inc. (NASDAQ: INV), has secured an exclusive license from Pacific Northwest National Laboratory (PNNL) to commercialize catalyst technology that converts waste plastic-derived light olefins into distillate-range hydrocarbons suitable for sustainable aviation fuel (SAF), renewable diesel, and lubricants. The com…

INV

Jun 22, 2026

Priya Menon

Press Releases

EagleNXT Secures Order of eBee VISION ISR and eBee TAC Systems from Asia Pacific Customer

AgEagle Aerial Systems Inc., operating as EagleNXT, announced an order for two eBee VISION ISR drones and three eBee TAC tactical mapping drones from a customer in the ASEAN region. These lightweight, rapidly deployable, and secure drones will enhance the customer's defense and operational capabilities. This deal highlights EagleNXT's expanding int…

UAVS

Jun 22, 2026

Hana Yamamoto

Press Releases

BitFuFu Announces US$5 Million Share Repurchase Program

BitFuFu Inc., a leading Bitcoin mining company listed on NASDAQ under ticker FUFU, has approved a $5 million share repurchase program to be executed over the next 24 months. The program reflects the company's confidence in its long-term growth prospects and aims to enhance shareholder value while maintaining financial flexibility to invest in expan…

FUFU

Jun 22, 2026

Marcus Reed

Press Releases

Country Stampede Breaks Attendance Records

Kustom Entertainment, Inc. announced record attendance exceeding 32,000 for its 30th anniversary Country Stampede Festival in Kansas. The company reported multiple ticket classes sold out, signaling strong consumer demand. Additionally, Kustom has partnered with Ruffin Properties to host multi-season music festivals at Gilley's Gambling Hall Park C…

KUST

Jun 22, 2026

Sofia Navarro

Press Releases

Rezolve Ai Powers New Mashreq and Visa Everyday Cashback Program, Bringing AI-Enabled Card Linked Offers to UAE Cardholders

Rezolve Ai announces its Reward platform is powering Everyday Cashback, a new Visa Card Linked Offers program launched by Mashreq bank in the UAE. This initiative allows Mashreq cardholders to receive up to 20% automated cashback at hundreds of merchants, utilizing AI-driven personalized offers. The launch expands Rezolve Ai's presence into payment…

RZLV

Jun 22, 2026

Sofia Navarro

Press Releases

NorthStar Secures Over CAD$40M with 3 Canadian Space Division to Advance Sovereign Space Domain Awareness

NorthStar Earth & Space, a Canadian-based company specializing in Space Situational and Domain Awareness, has secured commercial services contracts worth over CAD$40 million with the Royal Canadian Air Force's 3 Canadian Space Division. This partnership aims to integrate NorthStar's space-based surveillance technology to improve Canada's mission re…

VACI

Jun 22, 2026

Hana Yamamoto

Press Releases

Aptorum Group Announces Collaboration between DiamiR Biosciences and AlzLabs Precision Diagnostics for Alzheimer’s Disease Biomarkers

Aptorum Group Limited (NASDAQ: APM) announced a collaboration between DiamiR Biosciences and AlzLabs Precision Diagnostics to develop blood-based biomarker tests for Alzheimer’s disease. The focus is on protein and microRNA biomarkers such as p-Tau 217, amyloid 42/40, and neurofilament light to improve non-invasive diagnosis and monitoring of neuro…

APM

Jun 22, 2026

Marcus Reed

Press Releases

Genius Group Buys Back 6,037,851 Company Shares

Genius Group Limited (NYSE American: GNS) announced the purchase of over 6 million Class A Ordinary Shares in a privately negotiated deal, following a recent 6.6 million share buyback. These transactions contribute to the removal of 32.6 million shares from the company's issued capital within eight days, equating to 27% of the public float, aiming …

GNS

Jun 22, 2026

Caleb Monroe

Press Releases

Kyverna Therapeutics Appoints Ritesh Srivastava as Chief Legal and Compliance Officer, Adding Leadership Strength to Support Commercial-Stage Transition

Kyverna Therapeutics has appointed Ritesh Srivastava as Chief Legal and Compliance Officer to support its advancement towards potential commercialization of its lead CAR T-cell therapy, miv-cel, targeting autoimmune diseases such as stiff person syndrome. The appointment strengthens the company's executive team as it plans to transition into a comm…

KYTX

Jun 22, 2026

Sofia Navarro

Press Releases

Lifetime Brands, Inc. Announces Results of 2026 Annual Meeting

Lifetime Brands, Inc. reported the outcomes of its 2026 Annual Meeting of Stockholders, including director elections, ratification of Ernst & Young LLP as auditor, approval of 2025 executive compensation, and amendment to its Long-Term Incentive Plan. The company also declared a quarterly cash dividend of $0.0425 per share.

LCUT

Jun 22, 2026

Leila Farooq

Press Releases

GrowGeneration to Present at the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 on June 23, 2026

GrowGeneration Corp., a leading supplier of specialty products for controlled environment agriculture and commercial cultivation, announced that CEO Darren Lampert will present at the iAccess Alpha Virtual Best Ideas Summer Investment Conference on June 23, 2026. The company highlights its broad product offerings and business segments during this e…

GRWG

Jun 22, 2026

Sofia Navarro

Press Releases

Autonomix Medical Announces Standalone Neural Sensing Program with Evidence of Real-Time Renal Nerve Activity Change

Autonomix Medical announced successful preclinical development of a proprietary standalone neural sensing platform capable of detecting renal nerve activity and real-time changes following intervention. Built on the same technology as their pancreatic cancer pain program, this platform offers a capital-efficient path into cardiology, particularly r…

AMIX

Jun 22, 2026

Hana Yamamoto

Press Releases

Hyperion DeFi and Blockdaemon Partner to Expand Institutional Hyperliquid Staking Infrastructure

Hyperion DeFi, the first U.S. publicly listed DeFi company on Hyperliquid, announced a partnership with Blockdaemon to support Hyperliquid staking operations via the Kinetiq X Hyperion Validator. This collaboration aims to expand institutional access and infrastructure in the growing Hyperliquid decentralized trading ecosystem. The partnership enab…

HYPD

Jun 22, 2026

Ajmal Hussain

Press Releases

Nasus Pharma to Participate in the Zacks Life Sciences Investor Forum

Nasus Pharma Ltd., a clinical-stage pharmaceutical company specializing in intranasal powder drug delivery technology, announced its participation at the upcoming Zacks Life Sciences Investor Forum. The management will present their innovative intranasal products, including their needle-free epinephrine alternative NS002, and engage with investors …

NSRX

Jun 22, 2026

Marcus Reed

Press Releases

Revolution Medicines Announces Planned Leadership Transition for Steve Kelsey, M.D.

Revolution Medicines announces that Steve Kelsey, President of Research and Development, will transition to a senior advisor role effective July 1, 2026, ahead of his planned retirement in January 2027. The company also reveals a new R&D leadership structure to ensure ongoing strategic execution. Kelsey has played a key role in advancing the compan…

RVMD

Jun 22, 2026

Derek Hwang

Press Releases

Prime Medicine Receives U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)

Prime Medicine announced that the FDA has granted Regenerative Medicine Advanced Therapy (RMAT) designation to its investigational therapy PM359 for the treatment of p47phox-deficient chronic granulomatous disease (CGD). This designation, based on promising Phase 1/2 clinical data, enables early FDA engagement and expedited review pathways, reinfor…

PRME

Jun 22, 2026

Derek Hwang

Press Releases

Taysha Gene Therapies Announces Completion of Dosing in REVEAL Pivotal Trial and Reports Longer-Term Clinical Data from Part A of REVEAL Phase 1/2 Trials Evaluating TSHA-102 for Rett Syndrome

Taysha Gene Therapies announced the completion of dosing in its REVEAL pivotal trial evaluating TSHA-102 for Rett syndrome and reported positive longer-term clinical data from earlier phases. The gene therapy showed durable, clinically meaningful functional gains with no treatment-related serious adverse events. The company plans to submit a Biolog…

TSHA

Jun 22, 2026

Hana Yamamoto

Press Releases

Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation for Elsunersen for the Treatment of Seizures Associated with SCN2A Developmental and Epileptic Encephalopathy Caused by Gain of Function Variants

Praxis Precision Medicines has received FDA Breakthrough Therapy Designation (BTD) for elsunersen (PRAX-222), an antisense oligonucleotide targeting seizures in patients with SCN2A Developmental and Epileptic Encephalopathy (SCN2A-DEE) due to gain-of-function variants. The designation was based on positive results from the EMBRAVE Part A trial, whi…

PRAX